Common surgical drug may hold key to stopping lung Cancer's return
NCT ID NCT07347977
Summary
This study aims to see if giving the numbing medication lidocaine during and right after lung cancer surgery can help prevent the cancer from coming back or spreading. About 1,400 patients having minimally invasive surgery will be randomly assigned to receive either lidocaine or a placebo (saltwater) infusion. Researchers will track participants for three years after surgery to compare cancer recurrence and survival rates between the two groups.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL-CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The first affiliated hospital of Ningbo University
Ningbo, Zhejiang, 315000, China
Conditions
Explore the condition pages connected to this study.